anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
AstraZeneca · conference-presentation

AstraZeneca | Investor Event Presentation Deck | 42 slides

42 pages · 6 arc beats · 4 loops

Conference-Presentation Download JSON
Unlock

AstraZeneca | Investor Event Presentation Deck | 42 slides

AstraZeneca · 2022-12
arc beats above · slides in the middle · loops below · scroll → 4 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

6
coverage by narrative range · generated from this deck JSON
Narrative range 42 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Setup 5 slides 100% 5/5 slides 100% 5/5 slides · 32 hits
— 0/5 slides
20% 1/5 slides
— 0/5 slides
100% 5/5 slides
— 0/5 slides
Complication 4 slides 100% 4/4 slides 100% 4/4 slides · 23 hits
— 0/4 slides
— 0/4 slides
75% 3/4 slides 100% 4/4 slides
— 0/4 slides
Problem & Complication 9 slides 100% 9/9 slides 100% 9/9 slides · 49 hits
— 0/9 slides
55.6% 5/9 slides
— 0/9 slides
100% 9/9 slides 100% 9/9 slides Evidence & Proof 11 slides 100% 11/11 slides 100% 11/11 slides · 58 hits
— 0/11 slides
72.7% 8/11 slides 45.5% 5/11 slides 100% 11/11 slides 36.4% 4/11 slides Impact & Next Steps 8 slides 100% 8/8 slides 100% 8/8 slides · 50 hits
— 0/8 slides
62.5% 5/8 slides 37.5% 3/8 slides 100% 8/8 slides 37.5% 3/8 slides · 5 hits Action 5 slides 100% 5/5 slides 100% 5/5 slides · 21 hits
— 0/5 slides
— 0/5 slides
— 0/5 slides
100% 5/5 slides
— 0/5 slides

Slide inventory

42
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detailBeat · Setup
02
other
Open slide detailBeat · Setup
03
introduce_nominees
Open slide detailBeat · Setup
04
front_matter
Open slide detailBeat · Setup
05
introduce_nominees
Open slide detailBeat · Setup
06
Includes a footer with acronym definitions.summarize
Open slide detailBeat · Complication
07
The slide uses a four-column layout to segment strategic focus areas (HER2-high, HR+, gBRCA, TNBC).summarize
Open slide detailBeat · Complication
08
The slide uses a timeline framework to establish credibility and future-looking innovation.present_solution
Open slide detailBeat · Complication
09
The slide uses a horizontal timeline/process flow to map patient treatment stages against therapeutic interventions and resistance mechanisms.plan_implementation
Open slide detailBeat · Complication
10
front_matter
Open slide detailBeat · Problem & ComplicationLoop · Quick Win Big Bet
11
The slide uses a process flow diagram to illustrate the randomization of patients into treatment arms.establish_context
Open slide detailBeat · Problem & ComplicationLoop · Quick Win Big Bet
12
Includes a table of patients at risk below the x-axis and a summary table of PFS events, median PFS, and hazard ratio.analyze_data
Open slide detailBeat · Problem & ComplicationLoop · Quick Win Big Bet
13
Includes a table of PFS events, median PFS, and adjusted hazard ratio (HR) alongside the survival plot and risk table.analyze_data
Open slide detailBeat · Problem & ComplicationLoop · Quick Win Big Bet
14
Includes a risk table and summary statistics table (Median PFS, HR).analyze_data
Open slide detailBeat · Problem & ComplicationLoop · Quick Win Big Bet
15
Includes risk tables and hazard ratios (HR) with 95% confidence intervals.analyze_data
Open slide detailBeat · Problem & ComplicationLoop · Quick Win Big Bet
16
Includes a forest plot for subgroup analysis and a summary table for prior treatments.analyze_data
Open slide detailBeat · Problem & ComplicationLoop · Quick Win Big Bet
17
The slide uses a mirrored bar chart to compare adverse event frequencies by grade, alongside a summary table of clinical safety outcomes.analyze_data
Open slide detailBeat · Problem & ComplicationLoop · Quick Win Big Bet
18
summarize
Open slide detailBeat · Problem & ComplicationLoop · Quick Win Big Bet
19
Includes corporate branding, speaker name/title, and scientific imagery.front_matter
Open slide detailBeat · Evidence & Proof
20
The diagram illustrates a randomized clinical trial flow.present_framework
Open slide detailBeat · Evidence & Proof
21
The slide presents clinical trial baseline data, likely for a breast cancer study given the markers (ER+, PgR+, ESR1m, CDK4/6i).analyze_data
Open slide detailBeat · Evidence & Proof
22
The slide uses a standard Kaplan-Meier survival analysis framework common in oncology clinical trials.analyze_data
Open slide detailBeat · Evidence & ProofLoop · Before After
23
Clinical trial data visualization showing hazard ratios and median PFS.analyze_data
Open slide detailBeat · Evidence & ProofLoop · Before After
24
Clinical trial data visualization showing progression-free survival (PFS) curves with associated hazard ratios and event counts.analyze_data
Open slide detailBeat · Evidence & ProofLoop · Before After
25
The slide uses a split-panel design to compare two patient cohorts (ESR1m detectable vs not detectable).analyze_data
Open slide detailBeat · Evidence & ProofLoop · Before After
26
Clinical trial data visualization showing hazard ratios and median PFS.analyze_data
Open slide detailBeat · Evidence & Proof
27
The table compares adverse event (AE) frequencies, treatment-related AEs (TRAEs), and dose modifications.analyze_data
Open slide detailBeat · Evidence & Proof
28
The table lists 15 specific adverse events plus 'Any AE' across 4 cohorts, with two columns per cohort (All grades, Grade >=3).analyze_data
Open slide detailBeat · Evidence & Proof
29
The slide summarizes the primary outcomes of the SERENA-2 trial, confirming PFS benefits and safety, and mentions ongoing Phase III trials (SERENA-4 and SERENA-summarize
Open slide detailBeat · Evidence & Proof
30
SABCS stands for San Antonio Breast Cancer Symposium.transition
Open slide detailBeat · Impact & Next Steps
31
Includes Kaplan-Meier survival curve and key efficacy metrics.analyze_data
Open slide detailBeat · Impact & Next Steps
32
Includes a waterfall plot for the BEGONIA trial.summarize
Open slide detailBeat · Impact & Next Steps
33
front_matter
Open slide detailBeat · Impact & Next Steps
34
The slide uses a visual layout with three circular metrics to emphasize the scale of the problem.frame_problem
Open slide detailBeat · Impact & Next StepsLoop · Confession
35
The slide uses a patient journey/treatment pathway framework to map current standard of care against emerging therapeutic interventions.present_solution
Open slide detailBeat · Impact & Next StepsLoop · Confession
36
Uses a before-after-bridge structure to frame the problem (poor outcomes) and the solution (Capivasertib).diagnose_problem
Open slide detailBeat · Impact & Next StepsLoop · Confession
37
The slide uses a stacked bar chart to show market share evolution over three quarters and bulleted lists to summarize clinical trial outcomes.analyze_data
Open slide detailBeat · Impact & Next Steps
38
state_next_steps
Open slide detailBeat · Action
39
introduce_nominees
Open slide detailBeat · Action
40
appendix
Open slide detailBeat · Action
41
Clinical trial baseline characteristics table.analyze_data
Open slide detailBeat · Action
42
other
Open slide detailBeat · Action